Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
McKesson Corporation (NYSE: MCK) has agreed to sell its European operations in six countries, including France and Italy, to the PHOENIX group. The divestiture includes McKesson's German headquarters and various subsidiaries but excludes remaining operations in the UK and other Northern European countries. This strategic move aims to streamline McKesson's focus on growth outside Europe. The transaction is set to close in 2022, pending regulatory approvals. McKesson will discuss this sale further during its earnings call on August 4, 2021.
McKesson Corporation (NYSE: MCK) is set to release its first quarter fiscal 2022 financial results on August 4, 2021, after market close. A live webcast of the earnings conference call will be hosted at 4:30 PM ET, allowing investors to review the results. Interested parties can access the webcast on McKesson's Investor Relations website.
As a global leader in healthcare supply chain management and services, McKesson aims to innovate and provide effective healthcare solutions.
McKesson Corporation (NYSE:MCK) reported Q4 and FY21 results, showing FY21 revenues of $238.2 billion, a 3% increase. Q4 revenues were $59.1 billion, up 1%. Adjusted earnings per diluted share rose 15% for FY21 to $17.21. However, the company faced a significant loss of $28.26 per diluted share from continuing operations due to an $8.1 billion opioid-related liability. McKesson expects FY22 adjusted earnings per diluted share between $18.85 and $19.45, reflecting projected revenue growth of 3% to 6% and continued strong cash flow generation.
The Board of Directors of McKesson Corporation (NYSE: MCK) has declared a regular dividend of 42 cents per share of common stock. This dividend will be payable on July 1, 2021, to stockholders of record on June 1, 2021. McKesson is a leader in healthcare supply chain management and partners with various stakeholders in the healthcare sector to ensure safe and cost-effective distribution of medical products.
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast at 4:30 PM Eastern Time to discuss these results. Investors can access the webcast via McKesson's Investor Relations website, where additional financial information will also be available.
McKesson is recognized as a leader in healthcare supply chain management and has received multiple accolades, including being named a Most Admired Company in its industry.
McKesson Corporation (NYSE:MCK) reported third-quarter fiscal 2021 results, with revenues reaching $62.6 billion, a 6% increase from the previous year. Adjusted earnings per diluted share rose 21% to $4.60, driven by strong performance in U.S. Pharmaceuticals and Medical-Surgical Solutions segments. Despite an $8.1 billion pre-tax charge related to opioid litigation, the company successfully distributed COVID-19 vaccines and raised its adjusted earnings guidance for fiscal 2021 to $16.95-$17.25. The firm plans to repurchase an additional $2.0 billion in shares, reflecting confidence in its capital strategy.
The Board of Directors of McKesson Corporation (NYSE: MCK) announced a regular dividend of 42 cents per share. This dividend will be payable on April 1, 2021, to stockholders on record as of March 2, 2021. McKesson is recognized as a leader in healthcare supply chain management and has earned accolades such as being named a Most Admired Company in the healthcare sector by FORTUNE. The company is committed to providing essential healthcare solutions, ensuring timely access to medicines and medical products.
McKesson Corporation (NYSE:MCK) will announce its third quarter fiscal 2021 financial results on February 2, 2021, before market open. A live webcast of the earnings call will begin at 8:00 AM ET. The management will also participate in notable healthcare conferences, including the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference on January 5, 2021, and the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021. Investors can access the webcast and financial materials on McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has appointed Dr. Kelvin A. Baggett as the new chief impact officer, effective November 30, 2020. This role aims to enhance the company's focus on diversity, equity, inclusion, sustainability, and social impact. Dr. Baggett brings extensive healthcare leadership experience, having previously served at Health Care Navigator and Tenet Healthcare. His appointment is expected to help McKesson align its strategies with societal needs, impacting both employees and communities positively.
McKesson Corporation (NYSE: MCK) has appointed Linda Mantia as an independent director, expanding its board from 11 to 12 members, effective October 19, 2020. Mantia brings over 25 years of experience in financial services and operations, having held leadership roles at Manulife Financial and Royal Bank of Canada. Her election is expected to enhance strategic guidance during critical times for healthcare. Mantia also serves on several boards and committees, positioning her to positively impact McKesson Canada's growth initiatives.
FAQ
What is the current stock price of McKesson (MCK)?
What is the market cap of McKesson (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
